Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Apr-24 5:10 PM View:  | Howze Yalonda CHIEF LEGAL OFFICER | Generation Bio Co. (GBIO) | 15-Apr-24 | Option Exercise | 13,388 | -- | -- | 100% 0 to 13.39K | |
| 17-Apr-24 5:10 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 15-Apr-24 | Payment of Exercise | 468 | $3.70 | $1,731.60 | (3%) 14.28K to 13.81K | |
| 17-Apr-24 5:10 PM View: | Norkunas Matthew Chief Financial Officer | Generation Bio Co. (GBIO) | 15-Apr-24 | Option Exercise | 3,347 | -- | -- | 7% 50.26K to 53.61K | |
| 17-Apr-24 5:10 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 15-Apr-24 | Option Exercise | 1,147 | -- | -- | 1% 112.95K to 114.09K | |
| 17-Apr-24 5:10 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 15-Apr-24 | Option Exercise | 1,592 | -- | -- | 13% 12.68K to 14.28K | |
| 17-Apr-24 5:10 PM View: | McDonough Geoff PRESIDENT AND CEO Director | Generation Bio Co. (GBIO) | 15-Apr-24 | Payment of Exercise | 1,548 | $3.70 | $5,727.60 | (< 1%) 1.83M to 1.82M | |
| 17-Apr-24 5:10 PM View: | Stanton Matthew Chief Scientific Officer | Generation Bio Co. (GBIO) | 15-Apr-24 | Payment of Exercise | 492 | $3.70 | $1,820.40 | (< 1%) 245.45K to 244.96K | |
| 17-Apr-24 5:10 PM View: | Howze Yalonda CHIEF LEGAL OFFICER | Generation Bio Co. (GBIO) | 15-Apr-24 | Payment of Exercise | 3,930 | $3.70 | $14,541.00 | (29%) 13.39K to 9.46K | |
| 17-Apr-24 5:10 PM View: | Norkunas Matthew Chief Financial Officer | Generation Bio Co. (GBIO) | 15-Apr-24 | Payment of Exercise | 984 | $3.70 | $3,640.80 | (2%) 53.61K to 52.62K | |
| 17-Apr-24 5:10 PM View: | McDonough Geoff PRESIDENT AND CEO Director | Generation Bio Co. (GBIO) | 15-Apr-24 | Option Exercise | 5,274 | -- | -- | < 1% 1.82M to 1.83M | |
| 17-Apr-24 5:10 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 15-Apr-24 | Payment of Exercise | 337 | $3.70 | $1,246.90 | (< 1%) 114.09K to 113.76K | |
| 17-Apr-24 5:10 PM View: | Stanton Matthew Chief Scientific Officer | Generation Bio Co. (GBIO) | 15-Apr-24 | Option Exercise | 1,674 | -- | -- | < 1% 243.77K to 245.45K | |
| 31-Jan-24 4:30 PM View: | Kerr Douglas CHIEF MEDICAL OFFICER | Generation Bio Co. (GBIO) | 29-Jan-24 | Payment of Exercise | 1,476 | $1.90 | $2,804.40 | (< 1%) 387.1K to 385.63K | |
| 31-Jan-24 4:30 PM View: | Zimmermann Tracy Chief Development Officer | Generation Bio Co. (GBIO) | 29-Jan-24 | Payment of Exercise | 1,476 | $1.90 | $2,804.40 | (3%) 50.64K to 49.16K | |
| 31-Jan-24 4:30 PM View: | Kerr Douglas CHIEF MEDICAL OFFICER | Generation Bio Co. (GBIO) | 29-Jan-24 | Option Exercise | 5,021 | -- | -- | 1% 382.08K to 387.1K | |
| 31-Jan-24 4:30 PM View: | Zimmermann Tracy Chief Development Officer | Generation Bio Co. (GBIO) | 29-Jan-24 | Option Exercise | 5,021 | -- | -- | 11% 45.62K to 50.64K | |
| 17-Jan-24 5:00 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 3,637 | $1.91 | $6,946.67 | (22%) 16.32K to 12.68K | |
| 17-Jan-24 5:00 PM View: | Norkunas Matthew Chief Financial Officer | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 5,478 | $1.91 | $10,463.00 | (10%) 55.74K to 50.26K | |
| 17-Jan-24 5:00 PM View: | McDonough Geoff PRESIDENT AND CEO Director | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 44,531 | -- | -- | 2% 1.79M to 1.84M | |
| 17-Jan-24 5:00 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 8,712 | -- | -- | 8% 107.26K to 115.97K | |
| 17-Jan-24 5:00 PM View: | Stanton Matthew Chief Scientific Officer | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 14,131 | -- | -- | 6% 234.54K to 248.67K | |
| 17-Jan-24 5:00 PM View: | Kerr Douglas CHIEF MEDICAL OFFICER | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 14,131 | -- | -- | 4% 372.85K to 386.98K | |
| 17-Jan-24 5:00 PM View: | Zimmermann Tracy Chief Development Officer | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 14,131 | -- | -- | 39% 36.38K to 50.52K | |
| 17-Jan-24 5:00 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 10,492 | -- | -- | 180% 5.83K to 16.32K | |
| 17-Jan-24 5:00 PM View: | Norkunas Matthew Chief Financial Officer | Generation Bio Co. (GBIO) | 15-Jan-24 | Option Exercise | 15,805 | -- | -- | 40% 39.93K to 55.74K | |
| 17-Jan-24 5:00 PM View: | Kerr Douglas CHIEF MEDICAL OFFICER | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 4,897 | $1.91 | $9,353.27 | (1%) 386.98K to 382.08K | |
| 17-Jan-24 5:00 PM View: | Zimmermann Tracy Chief Development Officer | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 4,897 | $1.91 | $9,353.27 | (10%) 50.52K to 45.62K | |
| 17-Jan-24 5:00 PM View: | McDonough Geoff PRESIDENT AND CEO Director | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 15,431 | $1.91 | $29,473.20 | (< 1%) 1.84M to 1.82M | |
| 17-Jan-24 5:00 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 3,020 | $1.91 | $5,768.20 | (3%) 115.97K to 112.95K | |
| 17-Jan-24 5:00 PM View: | Stanton Matthew Chief Scientific Officer | Generation Bio Co. (GBIO) | 15-Jan-24 | Payment of Exercise | 4,897 | $1.91 | $9,353.27 | (2%) 248.67K to 243.77K | |
| 03-Jan-24 4:35 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 02-Jan-24 | Sale (Planned) | 2,445 | $1.62 | $3,960.90 | (2%) 109.7K to 107.26K | |
| 03-Jan-24 4:35 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 02-Jan-24 | Sale (Planned) | 2,445 | $1.62 | $3,960.90 | (30%) 8.27K to 5.83K | |
| 11-Dec-23 4:30 PM View: | Appelhans Dannielle Director | Generation Bio Co. (GBIO) | 08-Dec-23 | Private Purchase | 637 | $1.82 | $1,159.34 | 5% 12.0K to 12.64K | |
| 11-Dec-23 4:30 PM View: | Appelhans Dannielle Director | Generation Bio Co. (GBIO) | 08-Dec-23 | Purchase | 7,363 | $1.79 | $13,179.80 | 58% 12.64K to 20.0K | |
| 05-Dec-23 4:30 PM View: | Rowland Charles A Jr Director | Generation Bio Co. (GBIO) | 04-Dec-23 | Purchase | 150,000 | $1.50 | $225,000.00 | 39% 384.76K to 534.76K | |
| 06-Dec-23 4:30 PM View: | Appelhans Dannielle Director | Generation Bio Co. (GBIO) | 04-Dec-23 | Private Purchase | 12,000 | $1.50 | $18,000.00 | 100% 0 to 12.0K | |
| 05-Dec-23 4:30 PM View: | Rowland Charles A Jr Director | Generation Bio Co. (GBIO) | 01-Dec-23 | Private Purchase | 192,960 | $1.31 | $252,778.00 | 101% 191.8K to 384.76K | |
| 05-Dec-23 4:30 PM View: | Quinn Anthony Director | Generation Bio Co. (GBIO) | 01-Dec-23 | Private Purchase | 88,495 | $1.41 | $124,778.00 | 121% 72.84K to 161.33K | |
| 05-Dec-23 4:30 PM View: | Nicholson Donald William Director | Generation Bio Co. (GBIO) | 01-Dec-23 | Private Purchase | 100,000 | $1.44 | $144,000.00 | 88% 113.58K to 213.58K | |
| 17-Oct-23 6:00 PM View: | Norkunas Matthew Chief Financial Officer | Generation Bio Co. (GBIO) | 15-Oct-23 | Payment of Exercise | 2,675 | $3.24 | $8,667.00 | (6%) 42.61K to 39.93K | |
| 17-Oct-23 6:00 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 15-Oct-23 | Option Exercise | 4,125 | -- | -- | 4% 104.34K to 108.47K | |
| 17-Oct-23 6:00 PM View: | Kerr Douglas CHIEF MEDICAL OFFICER | Generation Bio Co. (GBIO) | 15-Oct-23 | Option Exercise | 7,437 | -- | -- | 2% 365.15K to 372.59K | |
| 17-Oct-23 6:00 PM View: | Zimmermann Tracy Chief Development Officer | Generation Bio Co. (GBIO) | 15-Oct-23 | Option Exercise | 7,437 | -- | -- | 24% 31.13K to 38.57K | |
| 17-Oct-23 6:00 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 15-Oct-23 | Option Exercise | 4,125 | -- | -- | 142% 2.91K to 7.04K | |
| 17-Oct-23 6:00 PM View: | McDonough Geoff PRESIDENT AND CEO Director | Generation Bio Co. (GBIO) | 15-Oct-23 | Option Exercise | 23,437 | -- | -- | 1% 1.78M to 1.8M | |
| 17-Oct-23 6:00 PM View: | Samayoa Phillip CHIEF STRATEGY OFFICER | Generation Bio Co. (GBIO) | 15-Oct-23 | Payment of Exercise | 1,211 | $3.24 | $3,923.64 | (1%) 108.47K to 107.26K | |
| 17-Oct-23 6:00 PM View: | Stanton Matthew Chief Scientific Officer | Generation Bio Co. (GBIO) | 15-Oct-23 | Option Exercise | 7,437 | -- | -- | 3% 229.28K to 236.72K | |
| 17-Oct-23 6:00 PM View: | Kerr Douglas CHIEF MEDICAL OFFICER | Generation Bio Co. (GBIO) | 15-Oct-23 | Payment of Exercise | 2,183 | $3.24 | $7,072.92 | (< 1%) 372.59K to 370.4K | |
| 17-Oct-23 6:00 PM View: | Zimmermann Tracy Chief Development Officer | Generation Bio Co. (GBIO) | 15-Oct-23 | Payment of Exercise | 2,183 | $3.24 | $7,072.92 | (6%) 38.57K to 36.38K | |
| 17-Oct-23 6:00 PM View: | Paone Antoinette CHIEF OPERATING OFFICER | Generation Bio Co. (GBIO) | 15-Oct-23 | Payment of Exercise | 1,211 | $3.24 | $3,923.64 | (17%) 7.04K to 5.83K |
